medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/ms2024-121medsovet-8184Research ArticleГОЛОВНАЯ БОЛЬ И ГОЛОВОКРУЖЕНИЕHEADACHE AND VERTIGOТранскраниальная электрическая стимуляция постоянным током при мигрениTranscranial direct current stimulation for migranehttps://orcid.org/0000-0002-6928-2355БордовскийС. П.BordovskyS. P.

Бордовский Сергей Петрович, аспирант кафедры нервных болезней и нейрохирургии Института клинической медицины имени Н.В. Склифосовского

119991, Москва, ул. Трубецкая, д. 8, стр. 2

Sergey P. Bordovsky, Postgraduate Student of the Department of Nervous Diseases and Neurosurgery, Institute of Clinical Medicine named after N.V. Sklifosovsky

8, Bldg. 2, Trubetskaya St., Moscow, 119991

sbordoche@gmail.comhttps://orcid.org/0000-0001-9734-7606АндреевС. С.AndreevS. S.

Андреев Сергей Степанович, стажер-исследователь, Центр нейроэкономики и когнитивных исследований, Институт когнитивных нейронаук

101000, Москва, ул. Мясницкая, д. 20

Sergey S. Andreev, Research Intern, Centre for Cognition and Decision Making, Institute for Cognitive Neuroscience

20, Myasnitskaya St., Moscow, 101000

ssandreev@hse.ruhttps://orcid.org/0000-0002-7976-3224ЗинченкоО. О.ZinchenkoO. O.

Зинченко Оксана Олеговна, к.псих.н., старший научный сотрудник Центра нейроэкономики и когнитивных исследований Института когнитивных нейронаук, доцент департамента психологии

101000, Москва, ул. Мясницкая, д. 20

Oksana O. Zinchenko, Cand. Sci. (Psych.), Senior Researcher at the Centre for Cognition and Decision Making, Institute for Cognitive Neuroscience

20, Myasnitskaya St., Moscow, 101000

ozinchenko@hse.ruhttps://orcid.org/0009-0003-0970-7934ПанинаУ. В.PaninaU. V.

Панина Ульяна Валерьевна, студент Института клинической медицины имени Н.В. Склифосовского

119991, Москва, ул. Трубецкая, д. 8, стр. 2

Uliana V. Panina, Student, Institute of Clinical Medicine named after N.V. Sklifosovsky

8, Bldg. 2, Trubetskaya St., Moscow, 119991

ulyapanina@gmail.ruhttps://orcid.org/0009-0008-7381-9814КотенкоВ. Д.KotenkoV. D.

Котенко Валентина Дмитриевна, студент Института клинической медицины имени Н.В. Склифосовского

 119991, Москва, ул. Трубецкая, д. 8, стр. 2

Valentina D. Kotenko, Student, Institute of Clinical Medicine named after N.V. Sklifosovsky

8, Bldg. 2, Trubetskaya St., Moscow, 119991

kotenko.tina1@inbox.ruhttps://orcid.org/0009-0000-2050-0553ТахировР. А.TakhirovR. A.

Тахиров Ренат Аснаилович, студент Института клинической медицины имени Н.В. Склифосовского

119991, Москва, ул. Трубецкая, д. 8, стр. 2

Renat A. Takhirov, Student, Institute of Clinical Medicine named after N.V. Sklifosovsky

8, Bldg. 2, Trubetskaya St., Moscow, 119991

kpyure@inbox.ruhttps://orcid.org/0009-0008-8448-6453ПотахинаА. Е.PotakhinaA. E.

Потахина Алина Евгеньевна, студент

117997, Москва, ул. Островитянова, д. 1

Alina E. Potakhina, Student

1, Ostrovityanov St., Moscow, 117997

alina.potakhina@yandex.ruhttps://orcid.org/0000-0002-9228-5108ШевцоваК. В.ShevtsovaK. V.

Шевцова Ксения Викторовна, ассистент кафедры нервных болезней и нейрохирургии Института клинической медицины имени Н.В. Склифосовского

119991, Москва, ул. Трубецкая, д. 8, стр. 2

Kseniya V. Shevtsova, Assistant, Department of Neurology and Neurosurgery, Institute of Clinical Medicine named after N.V. Sklifosovsky

8, Bldg. 2, Trubetskaya St., Moscow, 119991

dr.kseniya.shevtsova@gmail.comПервый Московский государственный медицинский университет имени И.М. СеченоваРоссияSechenov First Moscow State Medical University (Sechenov University)Russian FederationНациональный исследовательский университет «Высшая школа экономики»РоссияHSE UniversityRussian FederationПервый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)РоссияSechenov First Moscow State Medical University (Sechenov University)Russian FederationРоссийский национальный исследовательский медицинский университет имени Н.И. ПироговаРоссияPirogov Russian National Research Medical UniversityRussian Federation202401052024035159Copyright © Бордовский С.П., Андреев С.С., Зинченко О.О., Панина У.В., Котенко В.Д., Тахиров Р.А., Потахина А.Е., Шевцова К.В., 20242024Бордовский С.П., Андреев С.С., Зинченко О.О., Панина У.В., Котенко В.Д., Тахиров Р.А., Потахина А.Е., Шевцова К.В.Bordovsky S.P., Andreev S.S., Zinchenko O.O., Panina U.V., Kotenko V.D., Takhirov R.A., Potakhina A.E., Shevtsova K.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/8184

Мигрень – первичная головная боль с характерной клинической картиной, особенностями лечения и течения заболевания. В настоящий момент отмечается рост распространенности мигрени, что коррелирует с существенным снижением качества жизни пациентов, страдающих данной цефалгией. Терапия мигрени основана на применении двух стратегий: купировании приступа и его профилактике. В последнее время бурно развивается концепция первичной профилактической терапии мигрени, при этом, наряду со стандартными медикаментозными методами коррекции головной боли, все больше данных говорят о пользе и целесообразности введения в клиническую практику нелекарственных методов лечения, таких, например, как транскраниальная электрическая стимуляция (ТЭС). Свою эффективность для лечения мигрени показывают как катодная, так и анодная стимуляция: после применения курса ТЭС отмечено снижение количества дней в месяц с головной болью, уменьшение длительности и интенсивности мигренозных атак, некоторые исследования сообщают об уменьшении количества применяемых лекарственных препаратов. Наиболее часто область стимуляции коры головного мозга соответствовала зонам O1/O2 (1–2 мА) для катодной и F3/F4 (1–2 мА) для анодной стимуляции. Продолжительность каждой процедуры в среднем составила 20 мин, в то время как длительность сессий проведения ТЭС варьировалась в зависимости от конкретного исследования. ТЭС демонстрирует эффективность и безопасность в отношение лечения различных форм мигрени. Использование данного неинвазивного метода в профилактике приступов может послужить одним из направлений персонализации лечения мигрени.

Migraine is one of the most common primary headache disorders. Nowadays, there is an increase in the prevalence of migraine. It causes a significant reduction in the Quality of Life of those affected. There are two major approaches to treating migraines: attack management and prevention. The concept of primary prophylactic therapy of migraine has developed rapidly. In addition to standard medication, there are increasing data indicating the usefulness and feasibility of non-drug treatments, such as TES (transcranial electrical stimulation). Both cathodal and anodal stimulation have been shown to be effective in migraine treatment: after a course of TES, the number of days per month with headache decreased, the duration and intensity of migraine attacks decreased, and some studies reported a reduction in the number of medications used. O1/O2 (1–2 mA) for cathodal stimulation and F3/F4 (1–2 mA) for anodal stimulation were the most frequently stimulated cortical areas. The average duration of each session was 20 minutes. The length of TES sessions varied from study to study. TES has shown efficacy and safety in treating various forms of migraine. Using this non-invasive method to prevent attacks may be one of the directions for personalizing migraine treatment.

неинвазивная стимуляциякатодная стимуляция головного мозгаанодная стимуляция головного мозгахроническая мигреньэпизодическая мигреньабузусная головная больнемедикаментозная терапия головной болилечение хронической головной болиnon-invasive stimulationcathodal brain stimulationanodal brain stimulationchronic migraineepisodic migrainemedication overuse headachenon-medication headache therapychronic headache treatmentReferencesSteiner TJ, Stovner LJ. Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol. 2023;19(2):109–117. https://doi.org/10.1038/s41582-022-00763-1.Steiner TJ, Stovner LJ. Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol. 2023;19(2):109–117. https://doi.org/10.1038/s41582-022-00763-1. 2. Lew C, Punnapuzha S. Migraine Medications. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK553159.Lew C, Punnapuzha S. Migraine Medications. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK553159.Tabeeva GR, Katsapava Z. Current concept of the pathophysiology of migraine and new targets for its therapy. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):143–152. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-143-152.Табеева ГР, Кацарава З. Современная концепция патофизиологии и новые мишени терапии мигрени. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):143–152. https://doi.org/10.14412/2074-2711-2020-4-143-152.Sergeev AV, Tabeeva GR, Filatova EG, Amelin AV, Akhmadeeva LR, Lebedeva ER et al. Application of a new biological pathogenetic therapy of migraine in clinical practice: expert consensus of the Russian Headache Research Society. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(5):109–116. (In Russ.) https://doi.org/10.14412/2074-2711-2022-5-109-116.Сергеев АВ, Табеева ГР, Филатова ЕГ, Амелин АВ, Ахмадеева ЛР, Лебедева ЕР и др. Применение новой биологической патогенетической терапии мигрени в клинической практике: консенсус экспертов Российского общества по изучению головной боли. Неврология, нейропсихиатрия, психосоматика. 2022;14(5):109–116. https://doi.org/10.14412/2074-2711-2022-5-109-116.Lanteri-Minet M, Goadsby PJ, Reuter U, Wen S, Hours-Zesiger P, Ferrari MD, Klatt J. Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2–4 preventives were not useful: results from the LIBERTY study. J Neurol Neurosurg Psychiatry. 2021;92(5):466–472. https://doi.org/10.1136/jnnp-2020-324396.Lanteri-Minet M, Goadsby PJ, Reuter U, Wen S, Hours-Zesiger P, Ferrari MD, Klatt J. Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2–4 preventives were not useful: results from the LIBERTY study. J Neurol Neurosurg Psychiatry. 2021;92(5):466–472. https://doi.org/10.1136/jnnp-2020-324396.Tabeeva GR. Problems in the selection of effective analgesics for migraine. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(5):109–116. (In Russ.) https://doi.org/10.14412/2074-2711-2023-5-109-116.Табеева ГР. Проблемы выбора эффективного обезболивания при мигрени. Неврология, нейропсихиатрия, психосоматика. 2023;15(5):109–116. https://doi.org/10.14412/2074-2711-2023-5-109-116.Tabeeva GR, Amelin AV, Akhmadeeva LR, Danilov AB, Doronina OB, Koreshkina MI et al. Optimization of migraine attacks relief. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(2):126–133. (In Russ.) https://doi.org/10.14412/2074-2711-2023-2-126-133.Табеева ГР, Амелин АВ, Ахмадеева ЛР, Данилов АБ, Доронина ОБ, Корешкина МИ и др. Оптимизация купирования приступов мигрени. Неврология, нейропсихиатрия, психосоматика. 2023;15(2):126–133. https://doi.org/10.14412/2074-2711-2023-2-126-133.Filatova EG, Osipova VV, Tabeeva GR, Parfenov VA, Ekusheva EV, Azimova YuE et al. Diagnosis and treatment of migraine: Russian experts’ recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4–14. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-4-14.Филатова ЕГ, Осипова ВВ, Табеева ГР, Парфенов ВА, Екушева ЕА, Азимова ЮЭ и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):4–14. https://doi.org/10.14412/2074-2711-2020-4-4-14.Hepp Z, Dodick DW, Varon SF, Chia J, Matthew N, Gillard P et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis. Cephalalgia. 2017;37(5):470–485. https://doi.org/10.1177/0333102416678382.Hepp Z, Dodick DW, Varon SF, Chia J, Matthew N, Gillard P et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis. Cephalalgia. 2017;37(5):470–485. https://doi.org/10.1177/0333102416678382.Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, Lee S. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021;58(1). https://doi.org/10.3390/medicina58010044.Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, Lee S. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021;58(1). https://doi.org/10.3390/medicina58010044.Amatrudo G, Kengetter J, McCrea S, Amatrudo M. Cognitive Behavioral Therapy for the Management of Episodic Migraine. Curr Pain Headache Rep. 2023;27(9):471–477. https://doi.org/10.1007/s11916-023-01129-y.Amatrudo G, Kengetter J, McCrea S, Amatrudo M. Cognitive Behavioral Therapy for the Management of Episodic Migraine. Curr Pain Headache Rep. 2023;27(9):471–477. https://doi.org/10.1007/s11916-023-01129-y.Koechlin H, Coakley R, Schechter N, Werner C, Kossowsky J. The role of emotion regulation in chronic pain: A systematic literature review. J Psychosom Res. 2018;107:38–45. https://doi.org/10.1016/j.jpsychores.2018.02.002. 13. Thorn BE. Ronald Melzack Award Lecture: Putting the brain to work in cognitive behavioral therapy for chronic pain. Pain. 2020;161(Suppl. 1):S27–S35. https://doi.org/10.1097/j.pain.0000000000001839.Koechlin H, Coakley R, Schechter N, Werner C, Kossowsky J. The role of emotion regulation in chronic pain: A systematic literature review. J Psychosom Res. 2018;107:38–45. https://doi.org/10.1016/j.jpsychores.2018.02.002.Kroon Van Diest AM, Powers SW. Cognitive Behavioral Therapy for Pediatric Headache and Migraine: Why to Prescribe and What New Research Is Critical for Advancing Integrated Biobehavioral Care. Headache. 2019;59(2):289–297. https://doi.org/10.1111/head.13438.Thorn BE. Ronald Melzack Award Lecture: Putting the brain to work in cognitive behavioral therapy for chronic pain. Pain. 2020;161(Suppl. 1):S27–S35. https://doi.org/10.1097/j.pain.0000000000001839.Golovacheva VA, Golovacheva AA, Parfenov VA, Tabeeva GR, Romanov DV., Osipova VV., Katsarava Z. Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):74–80. (In Russ.) https://doi.org/10.14412/2074-2711-2021-1-74-80.Kroon Van Diest AM, Powers SW. Cognitive Behavioral Therapy for Pediatric Headache and Migraine: Why to Prescribe and What New Research Is Critical for Advancing Integrated Biobehavioral Care. Headache. 2019;59(2):289–297. https://doi.org/10.1111/head.13438.Rosignoli C, Ornello R, Onofri A, Caponnetto V, Grazzi L, Raggi A et al. Applying a biopsychosocial model to migraine: rationale and clinical implications. J Headache Pain. 2022;23(1):100. https://doi.org/10.1186/ s10194-022-01471-3.Головачева ВА, Головачева АА, Парфенов ВА, Табеева ГР, Романов ДВ, Осипова ВВ, Кацарава З. Когнитивно-поведенческая терапия в лечении хронической мигрени: описание клинического случая. Неврология, нейропсихиатрия, психосоматика. 2021;13(1):74–80. https://doi.org/10.14412/2074-2711-2021-1-74-80.Kulesh AA, Parfenov VA. Vestibular migraine: epidemiology, pathogenesis, clinical picture, diagnosis and treatment. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(6):4–11. (In Russ.) https://doi.org/10.14412/2074-2711-2022-6-4-11.Rosignoli C, Ornello R, Onofri A, Caponnetto V, Grazzi L, Raggi A et al. Applying a biopsychosocial model to migraine: rationale and clinical implications. J Headache Pain. 2022;23(1):100. https://doi.org/10.1186/s10194-022-01471-3.Woldeamanuel YW, Shrivastava S, Vila-Pueyo M. Editorial: Lifestyle modifications to manage migraine. Front Neurol. 2022;13:966424. https://doi.org/10.3389/fneur.2022.966424.Кулеш АА, Парфенов ВА. Вестибулярная мигрень: эпидемиология, патогенез, клиническая картина, диагностика и лечение. Неврология, нейропсихиатрия, психосоматика. 2022;14(6):4–11. https://doi.org/10.14412/2074-2711-2022-6-4-11.Bikson M, Esmaeilpour Z, Adair D, Kronberg G, Tyler WJ, Antal A et al. Transcranial electrical stimulation nomenclature. Brain Stimul. 2019;12(6):1349–1366. https://doi.org/10.1016/j.brs.2019.07.010.Woldeamanuel YW, Shrivastava S, Vila-Pueyo M. Editorial: Lifestyle modifications to manage migraine. Front Neurol. 2022;13:966424. https://doi.org/10.3389/fneur.2022.966424.Pelletier SJ, Cicchetti F. Cellular and molecular mechanisms of action of transcranial direct current stimulation: evidence from in vitro and in vivo models. Int J Neuropsychopharmacol. 2014;18(2):pyu047. https://doi.org/10.1093/ijnp/pyu047.Bikson M, Esmaeilpour Z, Adair D, Kronberg G, Tyler WJ, Antal A et al. Transcranial electrical stimulation nomenclature. Brain Stimul. 2019;12(6):1349–1366. https://doi.org/10.1016/j.brs.2019.07.010.Tabeeva GR, Filatova EG, Amelin AV, Osipova VV, Artemenko AR, Akhmadeeva LR et al. Alternative and complementary treatments for migraine. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(1):4–15. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1-4-15.Pelletier SJ, Cicchetti F. Cellular and molecular mechanisms of action of transcranial direct current stimulation: evidence from in vitro and in vivo models. Int J Neuropsychopharmacol. 2014;18(2):pyu047. https://doi.org/10.1093/ijnp/pyu047.Cai G, Xia Z, Charvet L, Xiao F, Datta A, Androulakis XM. A Systematic Review and Meta-Analysis on the Efficacy of Repeated Transcranial Direct Current Stimulation for Migraine. J Pain Res. 2021;14:1171–1183. https://doi.org/10.2147/jpr.s295704.Табеева ГР, Филатова ЕГ, Амелин АВ, Осипова ВВ, Артеменко АР, Ахмадеева ЛР и др. Альтернативные и комплементарные методы лечения мигрени. Неврология, нейропсихиатрия, психосоматика. 2024;16(1):4–15. https://doi.org/10.14412/2074-2711-2024-1-4-15.Dalla Volta G, Marceglia S, Zavarise P, Antonaci F. Cathodal tDCS Guided by Thermography as Adjunctive Therapy in Chronic Migraine Patients: A Sham-Controlled Pilot Study. Front Neurol. 2020;11:121. https://doi.org/10.3389/fneur.2020.00121.Cai G, Xia Z, Charvet L, Xiao F, Datta A, Androulakis XM. A Systematic Review and Meta-Analysis on the Efficacy of Repeated Transcranial Direct Current Stimulation for Migraine. J Pain Res. 2021;14:1171–1183. https://doi.org/10.2147/jpr.s295704.Hodaj H, Payen JF, Mick G, Vercueil L, Hodaj E, Dumolard A et al. Long-term prophylactic efficacy of transcranial direct current stimulation in chronic migraine. A randomised, patient-assessor blinded, sham-controlled trial. Brain Stimul. 2022;15(2):441–453. https://doi.org/10.1016/j.brs.2022.02.012.Dalla Volta G, Marceglia S, Zavarise P, Antonaci F. Cathodal tDCS Guided by Thermography as Adjunctive Therapy in Chronic Migraine Patients: A Sham-Controlled Pilot Study. Front Neurol. 2020;11:121. https://doi.org/10.3389/fneur.2020.00121.De Icco R, Putortì A, De Paoli I, Ferrara E, Cremascoli R, Terzaghi M et al. Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial. Clin Neurophysiol. 2021;132(1):126–136. https://doi.org/10.1016/j.clinph.2020.10.014.Hodaj H, Payen JF, Mick G, Vercueil L, Hodaj E, Dumolard A et al. Long-term prophylactic efficacy of transcranial direct current stimulation in chronic migraine. A randomised, patient-assessor blinded, sham-controlled trial. Brain Stimul. 2022;15(2):441–453. https://doi.org/10.1016/j.brs.2022.02.012.Mansour AG, Ahdab R, Khazen G, El-Khoury C, Sabbouh TM, Salem M et al. Transcranial Direct Current Stimulation of the Occipital Cortex in Medication Overuse Headache: A Pilot Randomized Controlled Cross-Over Study. J Clin Med. 2020;9(4):1075. https://doi.org/10.3390/jcm9041075.De Icco R, Putortì A, De Paoli I, Ferrara E, Cremascoli R, Terzaghi M et al. Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial. Clin Neurophysiol. 2021;132(1):126–136. https://doi.org/10.1016/j.clinph.2020.10.014.Pohl H, Moisa M, Jung HH, Brenner K, Aschmann J, Riederer F et al. Long-Term Effects of Self-Administered Transcranial Direct Current Stimulation in Episodic Migraine Prevention: Results of a Randomized Controlled Trial. Neuromodulation. 2021;24(5):890–898. https://doi.org/10.1111/ner.13292.Mansour AG, Ahdab R, Khazen G, El-Khoury C, Sabbouh TM, Salem M et al. Transcranial Direct Current Stimulation of the Occipital Cortex in Medication Overuse Headache: A Pilot Randomized Controlled Cross-Over Study. J Clin Med. 2020;9(4):1075. https://doi.org/10.3390/jcm9041075.Schading S, Pohl H, Gantenbein A, Luechinger R, Sandor P, Riederer F et al. Tracking tDCS induced grey matter changes in episodic migraine: a randomized controlled trial. J Headache Pain. 2021;22(1):139. https://doi.org/10.1186/s10194-021-01347-y.Pohl H, Moisa M, Jung HH, Brenner K, Aschmann J, Riederer F et al. Long-Term Effects of Self-Administered Transcranial Direct Current Stimulation in Episodic Migraine Prevention: Results of a Randomized Controlled Trial. Neuromodulation. 2021;24(5):890–898. https://doi.org/10.1111/ner.13292.Ahdab R, Mansour AG, Khazen G, El-Khoury C, Sabbouh TM, Salem M et al. Cathodal Transcranial Direct Current Stimulation of the Occipital cortex in Episodic Migraine: A Randomized Sham-Controlled Crossover Study. J Clin Med. 2019;9(1):60. https://doi.org/10.3390/jcm9010060.Schading S, Pohl H, Gantenbein A, Luechinger R, Sandor P, Riederer F et al. Tracking tDCS induced grey matter changes in episodic migraine: a randomized controlled trial. J Headache Pain. 2021;22(1):139. https://doi.org/10.1186/s10194-021-01347-y.Mastria G, Viganò A, Corrado A, Mancini V, Pirillo C, Badini S et al. Chronic Migraine Preventive Treatment by Prefrontal-Occipital Transcranial Direct Current Stimulation (tDCS): A Proof-of-Concept Study on the Effect of Psychiatric Comorbidities. Front Neurol. 2021;12:654900. https://doi.org/10.3389/fneur.2021.654900.Ahdab R, Mansour AG, Khazen G, El-Khoury C, Sabbouh TM, Salem M et al. Cathodal Transcranial Direct Current Stimulation of the Occipital cortex in Episodic Migraine: A Randomized Sham-Controlled Crossover Study. J Clin Med. 2019;9(1):60. https://doi.org/10.3390/jcm9010060.Hong P, Liu Y, Wan Y, Xiong H, Xu Y. Transcranial direct current stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials. CNS Neurosci Ther. 2022;28(7):992–998. https://doi.org/10.1111/cns.13843.Mastria G, Viganò A, Corrado A, Mancini V, Pirillo C, Badini S et al. Chronic Migraine Preventive Treatment by Prefrontal-Occipital Transcranial Direct Current Stimulation (tDCS): A Proof-of-Concept Study on the Effect of Psychiatric Comorbidities. Front Neurol. 2021;12:654900. https://doi.org/10.3389/fneur.2021.654900.Ornello R, Caponnetto V, Ratti S, D’Aurizio G, Rosignoli C, Pistoia F et al. Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials. J Headache Pain. 2021;22(1):144. https://doi.org/10.1186/s10194-021-01361-0.Hong P, Liu Y, Wan Y, Xiong H, Xu Y. Transcranial direct current stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials. CNS Neurosci Ther. 2022;28(7):992–998. https://doi.org/10.1111/cns.13843.Feng Y, Zhang B, Zhang J, Yin Y. Effects of Non-invasive Brain Stimulation on Headache Intensity and Frequency of Headache Attacks in Patients With Migraine: A Systematic Review and Meta-Analysis. Headache. 2019;59(9):1436–1447. https://doi.org/10.1111/head.13645.Ornello R, Caponnetto V, Ratti S, D’Aurizio G, Rosignoli C, Pistoia F et al. Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials. J Headache Pain. 2021;22(1):144. https://doi.org/10.1186/s10194-021-01361-0.Auvichayapat P, Janyacharoen T, Rotenberg A, Tiamkao S, Krisanaprakornkit T, Sinawat S, et al. Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial. J Med Assoc Thai. 2012;95(8):1003–1012. Available at: https://pubmed.ncbi.nlm.nih. gov/23061303/Feng Y, Zhang B, Zhang J, Yin Y. Effects of Non-invasive Brain Stimulation on Headache Intensity and Frequency of Headache Attacks in Patients With Migraine: A Systematic Review and Meta-Analysis. Headache. 2019;59(9):1436–1447. https://doi.org/10.1111/head.13645.Antal A, Kriener N, Lang N, Boros K, Paulus W. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia. 2011;31(7):820–828. https://doi.org/10.1177/0333102411399349.Auvichayapat P, Janyacharoen T, Rotenberg A, Tiamkao S, Krisanaprakornkit T, Sinawat S, et al. Migraine prophylaxis by anodal transcranial direct current stimulation, a randomized, placebo-controlled trial. J Med Assoc Thai. 2012;95(8):1003–1012. Available at: https://pubmed.ncbi.nlm.nih.gov/23061303/Rocha S, Melo L, Boudoux C, Foerster Á, Araújo D, Monte-Silva K. Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: A pilot randomized controlled trial. J Neurol Sci. 2015;349(1-2):33–39. https://doi.org/10.1016/j.jns.2014.12.018.Antal A, Kriener N, Lang N, Boros K, Paulus W. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia. 2011;31(7):820–828. https://doi.org/10.1177/0333102411399349.Antal A, Kriener N, Lang N, Boros K, Paulus W. Cathodal transcranial direct current stimulation of the visual cortex in the prophylactic treatment of migraine. Cephalalgia. 2011;31(7):820–828. https://doi.org/10.1177/0333102411399349.Rocha S, Melo L, Boudoux C, Foerster Á, Araújo D, Monte-Silva K. Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: A pilot randomized controlled trial. J Neurol Sci. 2015;349(1-2):33–39. https://doi.org/10.1016/j.jns.2014.12.018.Rocha S, Melo L, Boudoux C, Foerster Á, Araújo D, Monte-Silva K. Transcranial direct current stimulation in the prophylactic treatment of migraine based on interictal visual cortex excitability abnormalities: A pilot randomized controlled trial. J Neurol Sci. 2015;349(1-2):33–39. https://doi.org/10.1016/j.jns.2014.12.018.

The authors declare that there are no conflicts of interest present.